Jacques Galipeau

18.1k total citations · 4 hit papers
218 papers, 13.0k citations indexed

About

Jacques Galipeau is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Jacques Galipeau has authored 218 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Genetics, 78 papers in Molecular Biology and 64 papers in Immunology. Recurrent topics in Jacques Galipeau's work include Mesenchymal stem cell research (100 papers), Tissue Engineering and Regenerative Medicine (32 papers) and Immune Cell Function and Interaction (31 papers). Jacques Galipeau is often cited by papers focused on Mesenchymal stem cell research (100 papers), Tissue Engineering and Regenerative Medicine (32 papers) and Immune Cell Function and Interaction (31 papers). Jacques Galipeau collaborates with scholars based in United States, Canada and China. Jacques Galipeau's co-authors include Luc Sensebé, Moïra François, Nicoletta Eliopoulos, John Stagg, Raphaëlle Romieu‐Mourez, Ian B. Copland, Marie‐Noëlle Boivin, Laurence Lejeune, Sandra Pommey and Daniel L. Coutu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Jacques Galipeau

215 papers receiving 12.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities

2018 1.2k citations Jacques Galipeau et al. profile →
Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation

2011 548 citations Jacques Galipeau et al. profile →
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature

2019 542 citations Sowmya Viswanathan, Yufang Shi et al. Cytotherapy profile →
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells

2025 17 citations Katarina Le Blanc, Francesco Dazzi et al. Cytotherapy profile →

Peers

Countries citing papers authored by Jacques Galipeau

Since Specialization

Citations

This map shows the geographic impact of Jacques Galipeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Galipeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Galipeau more than expected).

Fields of papers citing papers by Jacques Galipeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Galipeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Galipeau. The network helps show where Jacques Galipeau may publish in the future.

Co-authorship network of co-authors of Jacques Galipeau

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Galipeau. A scholar is included among the top collaborators of Jacques Galipeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Galipeau. Jacques Galipeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Phase I Study Evaluating Safety and Tolerability of Viral‐Specific T Cells Against BK‐Virus in Adult Kidney Transplant Recipients 2025 ·Journal of Medical Virology ·(unknown), Ross O. Meyers, (unknown), Kimberly A. McDowell, Margaret R. Jorgenson, (unknown), Didier A. Mandelbrot, Jacques Galipeau, Sandesh Parajuli	1
2	ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells breakdown → 2025 ·Cytotherapy ·Katarina Le Blanc, Francesco Dazzi, Karen English, Dominique Farge, Jacques Galipeau, Edwin M. Horwitz, Nadir Kadri, Mauro Krampera, Manoj M. Lalu, Jan A. Nolta, Niketa Patel, Yufang Shi, Daniel J. Weiss, Sowmya Viswanathan	17
3	MESENCHYMAL STROMAL CELL (MSC) EXPRESSED TUMOR NECROSIS FACTOR-α (TNF-α) STIMULATED GENE-6 (TSG-6) AS A PLURIPOTENT REGULATOR OF CHEMOKINE ACTIVITY IN MONOCYTES-DERIVED MACROPHAGES (MDM). 2025 ·Cytotherapy ·Andrea Pennati, Xiao Tang, (unknown), Jacques Galipeau	0
4	Failure to launch commercially-approved mesenchymal stromal cell therapies: what's the path forward? Proceedings of the International Society for Cell & Gene Therapy (ISCT) Annual Meeting Roundtable held in May 2023, Palais des Congrès de Paris, Organized by the ISCT MSC Scientific Committee 2023 ·Cytotherapy ·Kevin P. Robb, Jacques Galipeau, Yufang Shi, M. Schuster, Iván Martín, Sowmya Viswanathan	17
5	An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue–derived MSCs for research purposes 2023 ·Cytotherapy ·Sowmya Viswanathan, Katarina Le Blanc, Rachele Ciccocioppo, Georges Dagher, Anthony J. Filiano, Jacques Galipeau, Mauro Krampera, (unknown), Manoj M. Lalu, Jan A. Nolta, (unknown), Yufang Shi, Karin Tarte, Daniel J. Weiss, Iván Martín	13
6	Washed Equine Platelet Extract as an Anti-Inflammatory Biologic Pharmaceutical 2020 ·Tissue Engineering Part A ·Andrea Pennati, (unknown), Sabrina H. Brounts, Jacques Galipeau	3
7	Challenges for mesenchymal stromal cell therapies 2019 ·Science Translational Medicine ·Iván Martín, Jacques Galipeau, (unknown), Katarina Le Blanc, Francesco Dazzi	125
8	Extracellular vesicles from bone marrow‐derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells 2018 ·Journal of Extracellular Vesicles ·Doan C. Nguyen, H Lewis, Chester J. Joyner, Vivien A. Warren, Haopeng Xiao, Haydn Kissick, Ronghu Wu, Jacques Galipeau, F. Eun‐Hyung Lee	24
9	Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion 2018 ·Nature Communications ·Doan C. Nguyen, (unknown), Haopeng Xiao, Shuya Kyu, Igor Albizua, Jacques Galipeau, Kuang‐Yueh Chiang, Edmund K. Waller, Ronghu Wu, Greg Gibson, James R. Roberson, Frances E. Lund, Troy D. Randall, Iñaki Sanz, F. Eun-Hyung Lee	86
10	Stimulation of Natural Killer Cell–Mediated Tumor Immunity by an IL15/TGFβ–Neutralizing Fusion Protein 2016 ·Cancer Research ·(unknown), Jiusheng Deng, Raghavan Chinnadurai, Shala Yuan, Andrea Pennati, Jacques Galipeau	17
11	Regulatory B Cells Induce Formation of IL-10-Expressing T Cells in Mice with Autoimmune Neuroinflammation 2016 ·Journal of Neuroscience Nursing ·Andrea Pennati, (unknown), (unknown), Jordan Murphy, Jiusheng Deng, Srikant Rangaraju, Pamela J. Shaw, Lori Blanchfield, Brian D. Evavold, Jacques Galipeau	19
12	Engineered Fusokine GIFT4 Licenses the Ability of B Cells to Trigger a Tumoricidal T-cell Response 2014 ·Cancer Research ·Jiusheng Deng, Shala Yuan, Andrea Pennati, Jordan Murphy, Jian Wu, David H. Lawson, Jacques Galipeau	25
13	B Effector Cells Activated by a Chimeric Protein Consisting of IL-2 and the Ectodomain of TGF-β Receptor II Induce Potent Antitumor Immunity 2012 ·Cancer Research ·(unknown), (unknown), (unknown), Elena Birman, Kathy Forner, Jacques Galipeau	11
14	The Human Ortholog of Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion Protein Induces Potent Ex vivo Natural Killer Cell Activation and Maturation 2009 ·Cancer Research ·(unknown), (unknown), (unknown), Jean‐Pierre Routy, Jacques Galipeau	19
15	Selective Inhibition of CCR2 Expressing Lymphomyeloid Cells in Experimental Autoimmune Encephalomyelitis by a GM-CSF-MCP1 Fusokine 2009 ·The Journal of Immunology ·Moutih Rafei, Philippe M. Campeau, Jian Wu, Elena Birman, Kathy Forner, Marie‐Noëlle Boivin, Jacques Galipeau	14
16	Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner 2009 ·The Journal of Immunology ·Moutih Rafei, Philippe M. Campeau, Adriana Aguilar‐Mahecha, Marguerite Buchanan, Patrick Williams, Elena Birman, Shala Yuan, Yoon Kow Young, Marie‐Noëlle Boivin, Kathy Forner, Mark Basik, Jacques Galipeau	296
17	Airway Delivery of Mesenchymal Stem Cells Prevents Arrested Alveolar Growth in Neonatal Lung Injury in Rats 2009 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), (unknown), Sébastien Bonnet, Gaël Y. Rochefort, John Akabutu, Manaf Bouchentouf, G Rey-Parra, Jacques Galipeau, Alois Haromy, Farah Eaton, Ming Chen, Kyoko Hashimoto, (unknown), Greg Korbutt, Stephen L. Archer, Bernard Thébaud	356
18	Design and Fabrication of 3D Porous Scaffolds to Facilitate Cell-Based Gene Therapy 2008 ·Tissue Engineering Part A ·(unknown), Nicoletta Eliopoulos, Robert DiRaddo, Jacques Galipeau, Azizeh‐Mitra Yousefi	35
19	Green Fluorescent Protein in Retroviral Vector Constructs as Marker and Reporter of Gene Expression for Cell and Gene Therapy Applications 2003 ·Humana Press eBooks ·Nicoletta Eliopoulos, Jacques Galipeau	4
20	Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages 2000 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), Dominique Shum‐Tim, Jacques Galipeau, Edgar Chedrawy, Nicoletta Eliopoulos, Ray C.‐J. Chiu	298

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact